GREY:DELCF - Post Discussion
Post by
yopmemama021 on Jun 23, 2021 5:33pm
DELC
$DELC @$0.305, tiny mc , trading 7X average volume
Matt Stang’s interview last week with CEO of Departure Capital
He discusses:
- the significance of their newly acquired KIC
- plan to expand the ketamine business and become the leading psychedelic clinic chain in America
- it means DELC can offer an entire customer journey from their multimedia informatory platform to their clinics
- by creating a self sustaining ecosystem where people can become curious, learn, gain knowledge and actually actively seek treatment
- the opportunity the psychedelic market holds
- major demand for novel interventions in various psychiatric crises
- addiction, PTSD, anxiety, depression
- beyond the clinical world, the wellness/ naturopathic market is massive
- observation into the multi trillion $ wellness market leads Matt Stang to believe the psychedelic market has potential to match that
- the difference between DELC and competitors
- Matt Stang believes the masses need this therapy and DELC ’s vision is making it accessible at all
- insurance accessible, price accessible
- putting centres in smaller places that don’t have as many people and resources
upcoming regulatory changes
- MDMA and psilocybin are both in phase 3 clinical trials with the FDA
- results from those trials expected by the end of the year
- considering the relative efficacy of these novel interventions (50-70%) compared to common pharmaceutical (4-5% effective in complete treatment of mental disorders) he predicts some sort of approval for both in 2022
full interview
https://www.youtube.com/watch?v=gfvlzTlGEh8
Be the first to comment on this post